Intratumor heterogeneity related signature for clinical outcome and immunotherapy advantages in lung adenocarcinoma
Overall, the study developed a unique IRS for LUAD that may serve as a predictor of the clinical outcome and immunotherapy advantages for individuals with LAUD.
Authors
- Yanhua Zuo
- Libo Sun (ORCID: https://orcid.org/0000-0001-5467-4797)
- Lin Li (ORCID: https://orcid.org/0009-0001-3363-6019)
Institutions
- Qingdao University (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-29
- DOI
- https://doi.org/10.1007/s12672-025-02173-3
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56